Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
The latest dividend from SNN was $0.482 per share (ex-dividend 3/27/2026). The dividend yield over the last 12 months is 2,7%. Over the last 12 months there were 2 distributions, totalling $0.782 per share.